CDC Recommends the First Updated COVID-19 Booster Targeting Omicron BA.4 and BA.5
CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendations for use of updated COVID-19 boosters from Pfizer-BioNTech for people ages 12 years and older and from Moderna for people ages 18 years and older.
CDC Report Says This Season’s Flu Vaccine Has Been 48% Effective So Far
The flu vaccine has been 48% effective so far this season, according to a report from the Centers for Disease Control and Prevention.
Cases Of The Seasonal Flu Have Reached Epidemic levels
Cases Of The Seasonal Flu Have Reached Epidemic levels
This is according to a report released by the U.S. Centers for Disease Control and Prevention.
This Year’s Flu Season Is Worse Than Last, CDC Says
Centers for Disease Control and Prevention “says this [flu] season is worse than last,” with “more than 10,000 cases reported nationwide.”
FDA Approves AspireAssist Device to Treat Obesity
The FDA has approved a surgically implanted weight-loss device that drains the contents of the stomach after meals.
Smokers are more likely to try quitting and succeed with graphic warnings on cigarette packs
Smokers are more likely to try quitting and more successful at quitting if they are given cigarette packs with graphic warnings compared to smokers given cigarette packs with only text warnings
Medical Errors Now Are The Third Leading Cause Of Death In The US
An average of 251,454 deaths per year in the United States are caused by medical error.
FDA Launches Campaign Against Teenage Smokeless Tobacco Use
Government health officials will team up with minor league baseball as part of a new $36 million campaign to discourage rural teenagers from using chewing tobacco.
E-cigarette Use Continued to Rise Among Young US Teenagers
About 5 percent of middle-school students reported using e-cigarettes in 2015, up from about 4 percent in 2014, according to data from the CDC and prevention.
FDA approves Cinqair to treat severe asthma
The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older.
Crash Risk Soars When Truck Drivers Don’t Treat Sleep Apnea
The study was published online March 21 in the journal Sleep.
“The most surprising result of our study is the strength and robustness of the increase in the crash risk for drivers with sleep apnea who fail to adhere to mandated treatment with positive airway pressure therapy [CPAP],” said study author Stephen Burks
Flu Vaccine Nearly 60 Percent Effective 2015-2016 Season
The Centers for Disease Control and Prevention today reported preliminary overall influenza vaccine effectiveness (VE) of 59 percent this season.